James L. Weemhoff
Impact in
- Pharmacology top 1%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
- Pharmacological Effects of Natural Compounds
- Hepatology top 5%
- Liver Disease and Transplantation
Papers in
- Pharmacology 13
- Drug-Induced Hepatotoxicity and Protection 9
- Pharmacogenetics and Drug Metabolism 4
-
- Connexins and lens biology 2
- Co-authors
- Hartmut Jaeschke (13 shared papers)David J. Greenblatt (4 shared papers)Lisa L. von Moltke (4 shared papers)Jerold S. Harmatz (3 shared papers)Kuo Du (4 shared papers)Anup Ramachandran (4 shared papers)Ikhlas A. Khan (1 shared paper)Erdal Bedіr (1 shared paper)
- Journals
- Archives of Toxicology (3 papers)The FASEB Journal (2 papers)Journal of Pharmacy and Pharmacology (2 papers)Biopharmaceutics & Drug Disposition (2 papers)Journal of Veterinary Internal Medicine (2 papers)
- Partner nations
- United StatesBelgiumBrazil
In The Last Decade
James L. Weemhoff
24 papers receiving 702 citations
Peers
Comparison fields: 5 of 97
- Pharmacology 273
- Hepatology 108
- Virology 33
- Complementary and alternative medicine 57
- Drug Discovery 1
Countries citing papers authored by James L. Weemhoff
This map shows the geographic impact of James L. Weemhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L. Weemhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L. Weemhoff more than expected).
Fields of papers citing papers by James L. Weemhoff
This network shows the impact of papers produced by James L. Weemhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L. Weemhoff. The network helps show where James L. Weemhoff may publish in the future.
Co-authors
The 25 scholars most cited alongside James L. Weemhoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 134 | |
| 2 | 2014 | 73 | |
| 3 | 2016 | 63 | |
| 4 | 2012 | 54 | |
| 5 | 2018 | 54 | |
| 6 | 2016 | 34 | |
| 7 | 2003 | 30 | |
| 8 | 2016 | 30 | |
| 9 | 2017 | 30 | |
| 10 | 2020 | 29 | |
| 11 | 2015 | 28 | |
| 12 | 2018 | 27 | |
| 13 | 2002 | 25 | |
| 14 | 2004 | 24 | |
| 15 | 2012 | 24 | |
| 16 | 2016 | 22 | |
| 17 | 2021 | 13 | |
| 18 | 2016 | 7 | |
| 19 | 2023 | 7 | |
| 20 | 2021 | 4 |
About James L. Weemhoff
James L. Weemhoff is a scholar working on Pharmacology, Molecular Biology, Oncology, Hepatology and Epidemiology, having authored 24 papers that have together received 721 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (9 papers), Drug Transport and Resistance Mechanisms (5 papers), Liver Disease Diagnosis and Treatment (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Liver Disease and Transplantation (4 papers), Dermatology and Skin Diseases (2 papers), Poisoning and overdose treatments (2 papers) and Connexins and lens biology (2 papers). The work is most often cited by research in Pharmacology (273 citations), Hepatology (108 citations), Virology (33 citations), Complementary and alternative medicine (57 citations) and Drug Discovery (1 citation). James L. Weemhoff has collaborated with scholars based in United States, Belgium and Brazil. Frequent co-authors include Hartmut Jaeschke, David J. Greenblatt, Lisa L. von Moltke, Jerold S. Harmatz, Kuo Du, Anup Ramachandran, Ikhlas A. Khan, Erdal Bedіr, Peter Goldman and Santosh Kumar. Their work appears in journals such as Archives of Toxicology, The FASEB Journal, Journal of Pharmacy and Pharmacology, Biopharmaceutics & Drug Disposition and Journal of Veterinary Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.